openPR Logo
Press release

Psychotic Disorder Treatment Market Sales Surge with Increasing Consumer Focus, reports Fact.MR study // Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V

06-11-2019 02:47 PM CET | Health & Medicine

Press release from: Fact.MR

Psychotic Disorder Treatment Market Sales Surge with

Burgeoning prevalence of lifestyle-related mental conditions coupled with the growing number of bipolar disorders has been necessitating the development of effective-psychotic disorder treatment. Surging number of patients suffering from bipolar disorders, depressive disorders, schizophrenia and other mental disorders are accelerating the traction for psychotic disorder treatment. 

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=568

Growing awareness about the vital role of early prevention of mental disorders in minimizing the damage caused by these conditions has the potential to drive the psychotic disorder treatment market in the coming years. Moreover, easy availability of psychotic drugs in hospital pharmacies, drug stores, commerce, and retail pharmacies are fueling their sales. These factors are driving growth in the Psychotic Disorder Treatment Market. 

The emergence of atypical antipsychotic drugs in the psychotic disorder treatment market has transformed the scenario of mental disorders.  Consequently, individuals with mental disorders no longer needed to be physically bound and could be managed with drug treatment and medication. 

The global psychotic disorder treatment market is anticipated to be driven by growing cases of mental disturbances, such as depression, trauma, and stress. Furthermore, growing inventions of the molecules and increasing healthcare and medical investment in the R&D of metal disorders are favoring growth of psychotic disorder market. 

The World Health Organization (WHO) estimates that more than 21 million people worldwide suffered from schizophrenia in 2016, and stated that one in two people with this condition don’t receive appropriate psychotic disorder treatment. This is further creating an opportunity for the stakeholders in the psychotic disorder treatment market to develop cost-effective medications to extend their reach to a wider target base.

Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable deal of research in nonpharmacologic treatment approaches opening a new avenue in the Global Psychotic Disorder Treatment Market. These approaches have gained significance of late as they help in boosting medication compliance in patients.

A successful psychotherapy appears promising for managing the patients and may help them adapt to real world faster. Thus, recent studies on cognitive therapy as an adjunct to medication for patients with psychotic disorders augur well for the market expansion. Psychoeducation is another area that merits attention among researchers. This is especially crucial for treating the recurrent episodes of hallucinations and delusions characterized in disorders that may persist life-long. Recent studies seek to shed light on cognitive models of psychotherapy in this regard. Clinicians have been harping on multilevel approach to assess the effectiveness of patient-directed psychoeducation. This is expected to open a new paradigm in the evolution of the market.

Psychotic disorders psychotic disorder treatment are mental disorders in which a person’s personality is affected severely due to brain damage. When a psychotic episode happens, a person becomes uncertain about reality and usually experiences delusions, hallucinations, off-the-wall behavior, incoherency and chaotic speech. Psychotic disorders generally shows two main symptoms that are hallucinations and delusions. Hallucinations are wrong perceptions, such as seeing, hearing or feeling something that is not present. Delusions are wrong beliefs, involving real-life conditions that could not be true, such as having a disease. Depending on the causes, psychotic disorder can come slowly or quickly. Psychosis is not a permanent state rather it can be cured. The exact cause of psychotic disorder is unclear but psychosis is usually results from brain abnormalities. Psychotic disorder can also be associated with dementia, stroke, schizophrenia, brain tumors, bipolar disorders, heavy use and adverse effect to alcohol or drugs. Medication plays an important role in the treatment of psychotic disorder. Highly-effective treatments are available to treat psychotic disorder which includes antipsychotic medication, cognitive behavioral therapy, supportive psychotherapy and case management.

To know more about the Psychotic Disorder Treatment Market Visit the link- https://www.factmr.com/report/568/psychotic-disorder-treatment-market

Psychotic Disorder Treatment Market: Drivers and Restraints

The global psychotic disorder treatment market is anticipated to register a significant CAGR over a forecast period. The increasing research and development activities for the new drugs and new combinations of drugs to minimize the adverse effects  of the antipsychotics drugs and increase safety and efficacy of the drug is anticipated to boost the demand for the psychotic disorder drugs and drives the global psychotic disorder treatment market. Increasing the number of prevalence of severe psychotic disorder is likely to fuel the growth of global psychotic disorder treatment market. The rising in the awareness among people is also anticipated to drives the global psychotic disorder treatment market.

However, the possible side effects of the antipsychotics drugs may hamper the demand for the psychotic disorder treatment and restrain the growth of the global psychotic disorder treatment market. Lack of specific drugs and methods is a significant challenge to ensure the treatment is another factor that hinder the demand for the psychotic disorder treatment and restrain the growth of global psychotic disorder treatment market.

Psychotic Disorder Treatment Market: Regional Outlook

On the basis of regional presence, the global psychotic disorder treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global psychotic disorder treatment market in terms of value due to increase in the number of prevalence of severe psychotic disorder among people and is anticipated to register a significant CAGR over a forecast period. APEJ is also contributing moderate shares to the market and is expected to show a robust growth to the global psychotic disorder treatment market. Europe is also most lucrative market for the psychotic disorder treatment market. MEA is at a nascent stage to the global psychotic disorder treatment market and anticipated to register a decent growth to the market over a forecast period. Overall, the global psychotic disorder treatment market is expected to show significant growth over a forecast period.

Psychotic Disorder Treatment Market: Key Players

Some of the major market players in psychotic disorder treatment market globally includes: Teva Pharmaceutical Industries Ltd, Sanofi S.A., Allergan, Plc, Pfizer Inc, Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V. and others. These companies are highly focused on the development of advanced Psychotic disorder treatment devices further contributing to the growth of psychotic disorder treatment globally.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=568

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psychotic Disorder Treatment Market Sales Surge with Increasing Consumer Focus, reports Fact.MR study // Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V here

News-ID: 1771564 • Views: 905

More Releases from Fact.MR

Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel
07-02-2020 | Health & Medicine
Fact.MR
Medical Device Contract Manufacturing Market Set for Strong Growth, Production F …
The medical device contract manufacturing market is poised to expand at a CAGR of 11.3% during the forecast period (2020-2026). This is attributed to rapidly evolving healthcare industry and increasing adoption of technologically advanced surgical procedures. A number of original equipment manufacturers (OEMs) and contract manufacturers have been focusing on advanced technologies such as robotics, 3D-printing, and minimally invasive surgeries. Mergers & acquisition activities among leading players have greatly accelerated
06-02-2020 | Health & Medicine
Fact.MR
Fluid Management Market Expected to Grow Amid Covid-19, Finds Fact.MR
Growing prevalence of chronic disease and an expansion in numbers of geriatric population is leading to an upward facing growth curve for global fluid management market over the period of 2020 to 2025, states Fact.MR. It projects a compound annual growth rate or CAGR of about 5.3% for the market over this period, helping the market push its worth up significantly. It is significant to note here that while number of

All 5 Releases


More Releases for Psychotic

Psychotic Disorder Treatment Market Value Share, Supply Demand, share and Value …
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
08-31-2018 | Health & Medicine
Fact.MR
Psychotic Disorder Treatment Market Scenario with Demand, Production, Growth Fac …
A fresh study, covering “Psychotic Disorder Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2027” has been broadcasted to wide online repository of FactMR, which presents deep focus on the Psychotic Disorder Treatment Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends
Psychotic Disorder Treatment Market Competitive Analysis 2017-2027
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
One of the most popular ADHD drugs may cause hallucinations and other psychotic …
In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder (ADHD) and narcolepsy. Methylphenidate is a stimulant that increases the activity of the central nervous system, helps to combat fatigue, improves
Psychotic Disorder Treatment Market Report Explored in Latest Research
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
Anti-Psychotic Drugs Market - Global Industry Analysis 2025
Anti-psychotic drugs, also called tranquilizers or neuroleptics, are a specific type of medication that are majorly used for the treatment of schizophrenia or bipolar disorder. They are used to manage psychosis, including hallucinations, delusions, and disordered thought of paranoia, among others. Anti-psychotic drugs are effective for the treatment of psychosis in a short duration. These drugs block the dopamine receptors in the dopaminergic pathways of the brain, thereby repressing the